The results show that one dysregulated pathway revolving around EGFR is likely to be associated with the primary subtype of glioblastoma, and the other dysregulated pathway revolving around TP53 is likely to be associated with the secondary subtype of glioblastoma. The gene discussed is EGFR; the disease is glioblastoma.